Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00022867 · ClinicalTrials.gov registry record · Phase 1
Encouraging Calcium Absorption and Bone Formation During Early Puberty
A Phase 1 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
NCT00022867 is a Phase 1 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 100 participants.
The verdict
NCT00022867, a Phase 1 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
Increasing bone mass during puberty can ultimately decrease the risk of developing osteoporosis, which causes bones to weaken and break more easily later in life. The purpose of this study is to compare calcium absorption and bone growth in boys and girls on diets including either a nondigestible oligosaccharide (NDO) or simple sugar.
Interventions
- DRUG Nondigestible oligosaccharide (NDO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-05 |
| Est. Completion | 2006-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00022867
The ClinicalTrials.gov registry entry for NCT00022867 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nondigestible oligosaccharide (NDO) is the first listed.
NCT00022867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00022867 about?
NCT00022867 is a clinical study titled "Encouraging Calcium Absorption and Bone Formation During Early Puberty". Increasing bone mass during puberty can ultimately decrease the risk of developing osteoporosis, which causes bones to weaken and break more easily later in life. The purpose of this study is to compare calcium absorption and bone growth in boys and girls on diets including either a nondigestible ol...
What is the current status of trial NCT00022867?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2001-05. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00022867?
The interventions under investigation include: Nondigestible oligosaccharide (NDO) (DRUG).
Who is sponsoring clinical trial NCT00022867?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.